Topic: Computational Science

In a recent study published in the Astrophysical Journal, LLNL researchers developed an innovative approach to map cosmic shear using linear algebra, statistics, and HPC.

Highlights include ML techniques for computed tomography, a scalable Gaussian process framework, safe and trustworthy AI, and autonomous multiscale simulations.

The latest issue of LLNL's magazine explains how the world’s most powerful supercomputer helps scientists safeguard the U.S. nuclear stockpile.

LLNL, Arizona State University and Michigan State University will dive deep into uncovering the compositions of 70 exoplanets through the Computing Grand Challenge Program, which allocates significant quantities of institutional computational resources to scientists to perform cutting-edge research.

LLNL's Bruce Hendrickson joins other HPC luminaries in this op-ed about the future of the field.

The latest episode of the Big Ideas Lab podcast investigates the use of artificial intelligence for drug discovery and other uses.

The team used a Bayesian approach to quantify metal strength uncertainty with tantalum and two common explosive materials and integrated it into a coupled metal/high-explosive model.

The DarkStar inverse design technique blends AI, machine learning, and advanced hydrodynamics simulations to optimize science and engineering solutions starting from the final state.

The Generative Unconstrained Intelligent Drug Engineering (GUIDE) program accelerates development of medical countermeasure candidates to redefine biological defense.

Held for the first time in a hybrid format, the multi-day MFEM workshop drew participants from around the globe.

In a groundbreaking development for computational science, a team of Tri-Lab researchers has unveiled a revolutionary approach to molecular dynamics simulations using the Cerebras Wafer-Scale Engine, the world’s largest computer chip.

An iconic LLNL computer code that has saved the automobile industry billions of dollars is the focus for the newest episode of the Big Ideas Lab Podcast.

LLNL is participating in the 36th annual Supercomputing Conference (SC24) in Atlanta on November 17–22, 2024.

A virtual reality training platform allows liver surgeons to prepare and train outside of the operating room.

Learn about the game-changing potential of El Capitan and discover how it will not only transform HPC and AI but also revolutionize scientific research across multiple domains.

A groundbreaking multidisciplinary team is combining the power of exascale computing with AI, advanced workflows, and GPU acceleration to advance scientific innovation and revolutionize digital design.

Follow along at your own pace through tutorials of several open-source HPC software projects.

The event attracted more than 60 attendees from diverse sectors and featured discussions aimed at fostering new collaborations with various DOE offices and national labs.

The collaboration has enabled expanding systems of the same architecture as LLNL’s upcoming exascale supercomputer, El Capitan, featuring AMD’s cutting-edge MI300A processors.

Ensuring researchers and policymakers can predict and prepare for the long-term effects of a changing climate is a central, motivating question for the Energy Exascale Earth System Model (E3SM) project.

The proposed Frontiers in Artificial Intelligence for Science, Security and Technology (FASST) initiative will advance national security; attract and build a talented workforce; harness AI for scientific discovery; address energy challenges; develop technical expertise necessary for AI governance.

This issue highlights some of CASC’s contributions to the DOE's Exascale Computing Project.

LLNL is applying ML to real-world applications on multiple scales. Researchers explain why water filtration, wildfires, and carbon capture are becoming more solvable thanks to groundbreaking data science methodologies on some of the world’s fastest computers.

Developed by LLNL and Portland State University researchers, innovative matrix-free solvers offer performance gains for complex multiphysics simulations.

In a milestone for supercomputing-aided drug design, LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer.